awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38497691-3EF0601F-25AF-4037-86D4-B804B71298DC
Q38497691-3EF0601F-25AF-4037-86D4-B804B71298DC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38497691-3EF0601F-25AF-4037-86D4-B804B71298DC
Once-weekly exenatide as a treatment for Type 2 diabetes.
P2860
Q38497691-3EF0601F-25AF-4037-86D4-B804B71298DC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38497691-3EF0601F-25AF-4037-86D4-B804B71298DC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
adf61c6da6479188aa940357dffa255477bd96a9
P2860
Long-term cost-consequence analysis of exenatide once weekly vs sitagliptin or pioglitazone for the treatment of type 2 diabetes patients in the United States.